Schonfeld Strategic Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-138,127
| Closed | -$895K | – | 2412 |
|
|
2025
Q1 | $895K | Buy |
+138,127
| New | +$895K | 0.01% | 1223 |
|
|
2024
Q4 | – | Sell |
-52,276
| Closed | -$392K | – | 2259 |
|
|
2024
Q3 | $392K | Sell |
52,276
-223,485
| -81% | -$1.67M | ﹤0.01% | 1398 |
|
|
2024
Q2 | $2.45M | Buy |
275,761
+253,395
| +1,133% | +$2.26M | 0.02% | 713 |
|
|
2024
Q1 | $227K | Buy |
+22,366
| New | +$227K | ﹤0.01% | 1562 |
|
|
2023
Q4 | – | Sell |
-162,128
| Closed | -$1.52M | – | 2086 |
|
|
2023
Q3 | $1.52M | Buy |
162,128
+138,387
| +583% | +$1.3M | 0.01% | 783 |
|
|
2023
Q2 | $582K | Buy |
+23,741
| New | +$582K | 0.01% | 1138 |
|
|
2023
Q1 | – | Sell |
-24,600
| Closed | -$623K | – | 2574 |
|
|
2022
Q4 | $623K | Sell |
24,600
-47,495
| -66% | -$1.2M | 0.01% | 1396 |
|
|
2022
Q3 | $1.39M | Buy |
72,095
+9,795
| +16% | +$189K | 0.01% | 1057 |
|
|
2022
Q2 | $1.59M | Buy |
62,300
+50,313
| +420% | +$1.28M | 0.02% | 759 |
|
|
2022
Q1 | $309K | Sell |
11,987
-9,313
| -44% | -$240K | ﹤0.01% | 1616 |
|
|
2021
Q4 | $892K | Buy |
+21,300
| New | +$892K | 0.01% | 927 |
|